Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $23.5000 (-5.24%) ($23.5000 - $25.4000) on Wed. Nov. 1, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.51% (three month average) | RSI | 39 | Latest Price | $23.5000(-5.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.4% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) SKYY(8%) TBT(8%) ARKK(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -5.755% in a week (0% probabilities). TLT(-8%) GLD(-8%) GDX(-8%) SLV(-6%) SIL(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.755% (StdDev 11.51%) | Hourly BBV | 0 () | Intraday Trend | -4.5% | | | |
|
Resistance Level | $24.6 | 5 Day Moving Average | $23.86(-1.51%) | 10 Day Moving Average | $23.54(-0.17%) | 20 Day Moving Average | $24.6(-4.47%) | To recent high | -31.9% | To recent low | 142.3% | Market Cap | $463m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |